# Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase)

> **NCT04278586** · NA · COMPLETED · sponsor: **Cambridge Health Alliance** · enrollment: 260 (actual)

## Conditions studied

- Opioid-use Disorder
- Stress Related Disorder
- Anxiety
- Pain Interference

## Interventions

- **BEHAVIORAL:** Live-Online M-ROCC
- **BEHAVIORAL:** Live-Online Control

## Key facts

- **NCT ID:** NCT04278586
- **Lead sponsor:** Cambridge Health Alliance
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-15
- **Primary completion:** 2023-09-19
- **Final completion:** 2023-09-19
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2025-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04278586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04278586, "Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04278586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*